The Cigna Group (CI) Operating Margin
- Operating margin · 12 months: Value 3.53%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 3.53% | Operating income / revenue. Period ending 2026-06-30. $9.96B ÷ $282.38B × 100 ≈ 3.53% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 9.96B USD | Operating Income (Loss) |
| Revenue | 282.38B USD | |
| Cost of products and services | 224.13B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 14.16B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9.96B | $282.38B | $224.13B | (m) | $14.16B | 3.53% |
| 2026-03-31 | $9.59B | $277.89B | $220.69B | (m) | $14.13B | 3.45% |
| 2025-12-31 | $9.20B | $274.90B | $214.99B | (m) | $14.62B | 3.35% |
| 2025-09-30 | $9.03B | $268.08B | $206.22B | (m) | $14.87B | 3.37% |
| 2025-06-30 | $9.03B | $262.02B | $198.25B | (m) | $15.10B | 3.44% |
| 2025-03-31 | $9.13B | $255.37B | $189.48B | (m) | $15.35B | 3.58% |
| 2024-12-31 | $9.42B | $247.12B | $182.51B | (m) | $14.84B | 3.81% |
| 2024-09-30 | $9.30B | $232.59B | $168.75B | (m) | $15.04B | 4.00% |
| 2024-06-30 | $8.97B | $217.94B | $154.82B | (m) | $15.24B | 4.11% |
| 2024-03-31 | $8.78B | $206.00B | $143.77B | (m) | $14.99B | 4.26% |
| 2023-12-31 | $8.54B | $195.26B | $133.80B | (m) | $14.82B | 4.37% |
| 2023-09-30 | $8.19B | $189.90B | $130.63B | (m) | $14.26B | 4.31% |
| 2023-06-30 | $8.09B | $186.13B | $128.77B | (m) | $13.62B | 4.35% |
| 2023-03-31 | $8.24B | $183.03B | $126.48B | (m) | $13.45B | 4.50% |
| 2022-12-31 | $8.41B | $180.52B | $124.83B | (m) | $13.19B | 4.66% |
| 2022-09-30 | $8.23B | $180.45B | $123.99B | (m) | $13.37B | 4.56% |
| 2022-06-30 | $8.38B | $179.46B | $122.28B | (m) | $13.31B | 4.67% |
| 2022-03-31 | $8.14B | $177.11B | $120.13B | (m) | $13.05B | 4.60% |
| 2021-12-31 | $7.93B | $174.08B | $117.55B | (m) | $13.03B | 4.56% |
| 2021-09-30 | $7.74B | $170.10B | $113.36B | (m) | $13.33B | 4.55% |
| 2021-06-30 | $7.56B | $166.77B | $109.92B | (m) | $13.54B | 4.53% |
| 2021-03-31 | $8.05B | $162.90B | $106.53B | (m) | $13.95B | 4.94% |
| 2020-12-31 | $8.15B | $160.40B | $103.48B | (m) | $14.07B | 5.08% |
| 2020-09-30 | $8.37B | $156.93B | $100.53B | (m) | $14.06B | 5.33% |
| 2020-06-30 | $8.38B | $154.53B | $98.46B | (m) | $14.18B | 5.43% |
| 2020-03-31 | $7.91B | $154.09B | $97.81B | (m) | $14.15B | 5.13% |
| 2019-12-31 | $8.08B | $153.57B | $97.67B | (m) | $14.05B | 5.26% |
| 2019-09-30 | $7.08B | $129.62B | $76.58B | (m) | $13.58B | 5.46% |
| 2019-06-30 | $6.08B | $102.52B | $52.63B | (m) | $13.04B | 5.93% |
| 2019-03-31 | $5.08B | $75.18B | $28.28B | (m) | $12.49B | 6.76% |
| 2018-12-31 | $4.16B | $48.65B | $4.79B | (m) | $11.93B | 8.55% |
| 2018-09-30 | (m) | $44.98B | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $43.90B | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $42.79B | (m) | (m) | (m) | (m) |
| 2017-12-31 | $3.94B | $41.81B | $2.46B | (m) | $10.03B | 9.43% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $3.09B | $39.84B | $2.47B | (m) | $9.79B | 7.75% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |